SOURCE: BioProgress PLC

February 27, 2007 02:03 ET

BioProgress PLC announces Notice of Preliminary Results

Cambridgeshire -- (MARKET WIRE) -- February 27, 2007 --

For Immediate Release                                           27 February 2007

                                BioProgress Plc

                         Notice of Preliminary Results

BioProgress PLC (AIM: BPRG; NASDAQ: BPRG) will be announcing its preliminary
results for the year ended 31 December 2006 on 19 April 2007.

For further information:

BioProgress Plc                                            + 44 (0) 1223 394 250
Hiral Patel, CFO

Buchanan Communications                                    + 44 (0) 20 7466 5000
Rebecca Skye Dietrich/Mark Court

About BioProgress

BioProgress plc is an innovative specialty pharmaceutical and healthcare
business based around its platform technologies in polymer and film systems.
Listed on London's AIM in May 2003 and on US NASDAQ in October 2004, the company
has over 80 patents granted or in application within 24 patent families and has
product development agreements and strategic alliances with several global
companies. As an integrated business, BioProgress has acquired sales and
marketing resources within Europe and the US as a launch mechanism for its own
pharmaceutical products. The business continues to develop innovative delivery
mechanisms using its XGEL(TM) polymer technology, replacing the need to use
animal-derived gelatine in pharmaceutical and healthcare products. For further
information please go to

Forward-Looking Information.

The Ordinary Shares of BioProgress plc are registered under the US Securities
and Exchange Act of 1934.  To the extent that this announcement contains certain
"forward-looking statements" within the meaning of the Private Securities
Litigation Reform Act of 1995, this paragraph applies.  These statements are
based on management's current expectations and are subject to uncertainty and
changes in circumstances.  Actual results may vary materially from the
expectations contained in the forward-looking statements.  The forward-looking
statements in this release include statements addressing future financial and
operating results and the timing and benefits of the reorganisation.  Detailed
information about factors pertinent to the business of the company that could
cause actual results to differ is set forth in the Company's filings with the
Securities and Exchange Commission.  The Company is under no obligation to (and
expressly disclaim any such obligation to) update or alter its forward-looking
statements whether as a result of new information, future events or otherwise.
This announcement is for information only and does not constitute an offer or
invitation to acquire or dispose of any securities or investment advice.  The
distribution of the announcement and/or issue of securities in certain
jurisdictions may be restricted by law.  Persons into whose possession this
announcement comes are required to inform themselves about and to observe such

                      This information is provided by RNS
            The company news service from the London Stock Exchange